Opinion

Video

Bispecific Therapies: Current and Future Considerations

With their closing thoughts, the panelists provide their key takeaways from this discussion surrounding the operationalization of bispecifics.

The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Sundar Jagannath
1 expert in this video
4 experts in this video
4 experts in this video
Dr Caroline Vovan
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo